iRhythm SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewediRhythm Holdings Q3 2026 adjusted EPS of $0.82 beats $0.05 consensus on $221.6 million revenue, in line; FY2026 revenue guidance raised to $890 million-$895 million
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewediRhythm Completes $237.5 Million Cash Acquisition of VitalConnect, Expanding Cardiac Monitoring Portfolio
Regulation FD disclosure
Departure/appointment of directors or officers
Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits
Entry into a material definitive agreement · Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits